Diabetes: Medical Equipment

(asked on 18th March 2020) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 12 March 2020 to Question 26807 on Diabetes: Medical Equipment, what (a) national and (b) regional data NHS England and NHS Improvement hold on the prescription of flash glucose monitors by primary care providers.


Answered by
Jo Churchill Portrait
Jo Churchill
Minister of State (Department for Work and Pensions)
This question was answered on 22nd April 2020

The information requested is shown in the following table.

Flash Glucose Monitoring Patient Numbers – Q3 2019/20

Number of Identified Patients with Prescriptions

Q1 Uptake

Q2 Uptake

Q3 Uptake

Region

Estimated # of Type 1 patients in the region

#

%

#

%

#

%

North West

30,630

6,084

20

7,836

26

9,325

30

North East and Yorkshire

40,490

989

2

5,672

14

8,640

21

Midlands

46,455

6,109

13

8,849

19

11,534

25

East

29,635

1,493

5

3,127

11

4,633

16

London

29,565

3,382

11

4,574

15

5,975

20

South West

26,875

4,171

16

5,748

21

6,924

26

South East

39,275

6,231

16

8,530

22

10,751

27

England

242,925

28,459

12

44,336

18

57,782

24

Source: NHS Business Services Authority

Notes:

- These figures represent patient numbers in receipt of flash in primary care.

- Flash Glucose Monitoring uptake has increased markedly in all regions – national uptake is now 24% of all type 1 patients.

- Figures only correspond to individual identified patients with clinical commissioning group prescriptions and may therefore understate full coverage.

Estimated number of type 1 patients sourced from National Diabetes Audit 2017/18

Reticulating Splines